PMID: 833720Jan 1, 1977Paper

Pharmaceutical salts

Journal of Pharmaceutical Sciences
S M BergeD C Monkhouse


No abstract listed.


Feb 1, 1975·Journal of Pharmaceutical Sciences·A A Sinkula, S H Yalkowsky
Nov 1, 1970·Journal of Pharmaceutical Sciences·H C CaldwellD Ziv
Jul 1, 1968·The Journal of Pharmacy and Pharmacology·D D Heard, R W Ashworth
Mar 1, 1969·Journal of Pharmaceutical Sciences·G M IrwinJ V Swintosky
Oct 1, 1970·The Journal of Pharmacy and Pharmacology·J H Perrin, J J Vallner
Oct 1, 1971·Journal of Pharmaceutical Sciences·S Borodkin, D P Sundberg
Mar 1, 1972·Psychosomatics·H L Goldberg, L Nathan
Dec 1, 1972·Journal of Pharmaceutical Sciences·S F Kramer, G L Flynn
Jul 1, 1972·Chemical & Pharmaceutical Bulletin·R A RunkelE Segre
May 1, 1974·Journal of Pharmaceutical Sciences·S H WanD L Azarnoff
Jul 1, 1971·Toxicology and Applied Pharmacology·C M GruberP M Terrill
Jul 1, 1965·Journal of Pharmaceutical Sciences·A C Glasser, R M Doughty
Aug 1, 1970·Journal of Pharmaceutical Sciences·V C WaltonG B Selzer
Jan 8, 1972·British Medical Journal·S S Davis
Jul 1, 1972·Journal of Pharmaceutical Sciences·F R SidellA Kaminskis
Jun 1, 1972·Journal of Pharmaceutical Sciences·S P Loucas, H M Haddad
Feb 1, 1972·Journal of Pharmaceutical Sciences·J J SciarraA L Kapoor
Mar 1, 1972·Journal of Pharmaceutical Sciences·R G Wiegand, A H Chun
Dec 1, 1969·Journal of Pharmaceutical Sciences·W A CressmanG A Braun
Mar 1, 1971·Journal of Pharmaceutical Sciences·G A Neville, J C Ethier
Jul 1, 1968·Journal of Pharmaceutical Sciences·A A KondritzerS H Paplanus
Aug 1, 1968·Journal of Pharmaceutical Sciences·P Finholt, S Solvang
Mar 1, 1969·Journal of Pharmaceutical Sciences·P H JonesA H Chun
May 1, 1969·Journal of Pharmaceutical Sciences·G Fiese, J H Perrin
Jul 1, 1965·Journal of Pharmaceutical Sciences·O Wulff
Jul 1, 1965·Journal of Pharmaceutical Sciences·B J Magerlein
May 1, 1966·Biochemical Pharmacology·G Zografi, I Zarenda
Jul 1, 1967·Journal of Pharmaceutical Sciences·J M PlaxcoC R Rowland
Oct 1, 1967·Journal of Pharmaceutical Sciences·A J AguiarA W Kinkel
Oct 1, 1954·The Journal of Pharmacy and Pharmacology·M T DAVIESV PETROW
Jan 1, 1956·Scandinavian Journal of Clinical and Laboratory Investigation·W J KAIPAINEN, P HARKONEN
Oct 1, 1956·Diseases of the Chest·R V COHENC J ZARAFONETIS
Dec 1, 1956·Acta Radiologica·R PETERHOFF
May 1, 1957·Journal of Neurosurgery·D H OSTERBERG
Jan 18, 1958·Nature·F A ALVESH L BAPTISTA
Dec 27, 1958·British Medical Journal·L G GOODWINO D STANDEN
Dec 27, 1958·British Medical Journal·E W ROGERS
Apr 1, 1959·Acta Radiologica· HOLMDAHL KH SON, H LODIN

❮ Previous
Next ❯


Oct 21, 2010·Annals of Biomedical Engineering·Ece Dilber GamsizRebecca Lyn Carrier
Aug 19, 2007·Pharmaceutical Research·Srinivas BasavojuSitaram P Velaga
Nov 14, 2008·Pharmaceutical Research·Anne ZimmermannLars Hovgaard
Jul 1, 1987·Toxicology·R W Busker, G M Beijersbergen van Henegouwen
Sep 1, 1991·Journal of Ethnopharmacology·D W UnanderB S Blumberg
Jun 1, 1996·Journal of Ethnopharmacology·A BrantnerA Antolić
Jan 1, 1990·Journal of Pharmaceutical and Biomedical Analysis·T Saesmaa, A M Tötterman
Feb 14, 2004·Advanced Drug Delivery Reviews·Barbara Rodríguez-SpongNaír Rodríguez-Hornedo
Feb 14, 2004·Advanced Drug Delivery Reviews·Sherry L MorissetteColin R Gardner
Mar 22, 2005·International Journal of Pharmaceutics·Hirofumi TakeuchiYoshiaki Kawashima
Apr 18, 2000·International Journal of Pharmaceutics·G A Stephenson, B A Diseroad
Jul 6, 2000·International Journal of Pharmaceutics·R Panchagnula, N S Thomas
Apr 18, 2000·International Journal of Pharmaceutics·G L EngelL L Winneroski
Sep 5, 2001·International Journal of Pharmaceutics·K M O'Connor, O I Corrigan
Jul 5, 2003·International Journal of Pharmaceutics·Paola MuraMarzia Cirri
Sep 30, 1999·International Journal of Pharmaceutics·A FiniL Rodriguez
Apr 12, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A FiniG Fazio
May 31, 2012·Molecular Pharmaceutics·David R WeynaJuan R Sanchez-Ramos
May 8, 2010·Chemical Communications : Chem Comm·Katharina Bica, Robin D Rogers
Dec 16, 2005·AAPS PharmSciTech·Stephen G MachathaSamuel H Yalkowsky
Jun 7, 2012·AAPS PharmSciTech·Neeraj KumarAsim Kumar Jana
Dec 20, 2012·AAPS PharmSciTech·Lokesh KumarArvind K Bansal
Apr 19, 2013·AAPS PharmSciTech·Lokesh KumarArvind Bansal
Jul 1, 2008·Indian Journal of Pharmaceutical Sciences·T D NandgudeV B Gupta
May 27, 2010·Indian Journal of Pharmaceutical Sciences·A V YadavS S Sakhare
Jul 1, 2009·Future Medicinal Chemistry·Martin J GarlandRyan F Donnelly
Jun 10, 2014·Annual Review of Chemical and Biomolecular Engineering·I M MarruchoL P N Rebelo
Sep 16, 2014·International Journal of Pharmaceutics·Jenna L Terebetski, Bozena Michniak-Kohn
Aug 23, 2008·Pharmaceutical Development and Technology·Lokesh KumarArvind K Bansal
Dec 8, 2000·Pharmaceutical Development and Technology·M Sacchetti
Mar 3, 2012·Drug Development and Industrial Pharmacy·Benjamin M CollmanAnthony C Blackburn
Jun 26, 2013·Expert Opinion on Drug Delivery·Julia L ShamshinaRobin D Rogers
Sep 7, 2012·Expert Opinion on Drug Metabolism & Toxicology·Evan A Thackaberry
Mar 29, 2013·Expert Opinion on Drug Delivery·Sonali S Bharate, Ram A Vishwakarma

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.